Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens.

Kench JG, Clouston DR, Delprado W, Eade T, Ellis D, Horvath LG, Samaratunga H, Stahl J, Stapleton AM, Egevad L, Srigley JR, Delahunt B.

Pathology. 2011 Aug;43(5):410-9. doi: 10.1097/PAT.0b013e328348a6b3. Review.

PMID:
21716159
2.

Abnormal PSA tests--delays in referral.

Stapleton AM, Johns RL, Kopsaftis T, Tamblyn DJ, Pinnock CB.

Aust Fam Physician. 2008 Jan-Feb;37(1-2):84-8.

PMID:
18239761
3.

Nomograms for prostate cancer--is their use evidence-based?

Stapleton AM, Pinnock CB.

Nat Clin Pract Urol. 2005 Oct;2(10):462-3. No abstract available.

PMID:
16474602
4.

Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.

Hall RE, Horsfall DJ, Stahl J, Vivekanandan S, Ricciardelli C, Stapleton AM, Scardino PT, Neufing P, Tilley WD.

Prostate. 2004 Feb 1;58(2):103-8.

PMID:
14716735
5.
6.

Attitudes to evidence-based practice in urology: results of a survey.

Stapleton AM, Cuncins-Hearn A, Pinnock C.

ANZ J Surg. 2001 May;71(5):297-300.

PMID:
11374480
7.

Simple, sensitive and accurate method for the quantification of prothrombin mRNA by using competitive PCR.

Grover PK, Stapleton AM, Miyazawa K, Ryall RL.

Biochem J. 2001 May 15;356(Pt 1):111-20.

8.

CD40 is not detected on human prostate cancer cells by immunohistologic techniques.

Moghaddami M, Cohen P, Stapleton AM, Brown MP.

Urology. 2001 Mar;57(3):573-8.

PMID:
11248650
9.

Factors predicting recovery of erections after radical prostatectomy.

Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT.

J Urol. 2000 Dec;164(6):1929-34.

PMID:
11061884
10.

The prothrombin gene is expressed in the rat kidney: Implications for urolithiasis research.

Grover PK, Dogra SC, Davidson BP, Stapleton AM, Ryall RL.

Eur J Biochem. 2000 Jan;267(1):61-7.

11.

Erectile dysfunction in the community: a prevalence study.

Pinnock CB, Stapleton AM, Marshall VR.

Med J Aust. 1999 Oct 4;171(7):353-7.

PMID:
10590723
12.

Prothrombin gene expression in rat kidneys provides an opportunity to examine its role in urinary stone pathogenesis.

Grover PK, Stapleton AM, Ryall RL.

J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S404-7.

PMID:
10541273
13.

Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease.

Stapleton AM, Timme TL, Ryall RL.

Br J Urol. 1998 May;81(5):666-71; discussion 671-2.

PMID:
9634038
14.

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT.

J Natl Cancer Inst. 1998 May 20;90(10):766-71.

PMID:
9605647
15.

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.

Stapleton AM, Zbell P, Kattan MW, Yang G, Wheeler TM, Scardino PT, Thompson TC.

Cancer. 1998 Jan 1;82(1):168-75.

PMID:
9428494
16.

Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.

Stapleton AM, Timme TL, Gousse AE, Li QF, Tobon AA, Kattan MW, Slawin KM, Wheeler TM, Scardino PT, Thompson TC.

Clin Cancer Res. 1997 Aug;3(8):1389-97.

17.

Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma.

Kattan MW, Stapleton AM, Wheeler TM, Scardino PT.

Cancer. 1997 Feb 1;79(3):528-37.

PMID:
9028364
18.

Human cytomegalovirus is not implicated in benign prostatic hyperplasia: a study using immunohistochemistry and the polymerase chain reaction.

Stapleton AM, Williams RH, Timme TL, Yang G, Truong LD, Thompson TC.

J Urol. 1996 Aug;156(2 Pt 1):542-5.

PMID:
8683733
19.

Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study.

Williams RH, Stapleton AM, Yang G, Truong LD, Rogers E, Timme TL, Wheeler TM, Scardino PT, Thompson TC.

Clin Cancer Res. 1996 Apr;2(4):635-40.

20.

Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix.

Stapleton AM, Dawson CJ, Grover PK, Hohmann A, Comacchio R, Boswarva V, Tang Y, Ryall RL.

Kidney Int. 1996 Mar;49(3):880-8.

Supplemental Content

Loading ...
Support Center